POLITICO @politico
The Novavax vaccine proved just as potent as the mRNA shots from Pfizer and Moderna in a U.K. trial, and the company is now preparing to file for U.S. authorization in a matter of weeks — potentially leapfrogging AstraZeneca, a former frontrunner https://t.co/aDWN7StRjM — PolitiTweet.org